Viewpoint discusses plateau in autoantibody discovery in autoimmune encephalitis, suggesting new beneficial efforts for patients.
This Viewpoint describes a plateau in the discovery of clinically meaningful autoantibodies in autoimmune encephalitis (AE) and suggests efforts that are likely to offer greater benefits to patients living with AE.
No takes yet. Share an insight, caveat, or question.
Takegami et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: